Press Releases :: Aethlon Medical, Inc. (AEMD)

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Year

Category

May 2, 2022

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Mar 28, 2022

Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

Feb 14, 2022

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Jan 31, 2022

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

Nov 9, 2021

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Nov 2, 2021

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

Oct 12, 2021

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Sep 30, 2021

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

Sep 7, 2021

Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 9, 2021

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

rss_feed News RSS